Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Britta Galling

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
The Journal of Clinical Psychiatry|January 10, 2017
Extent, Time Course, and Moderators of Antipsychotic Treatment in Youth With Mood Disorders: Results of a Meta-Analysis and Meta-Regression AnalysesChiara Cervesi, Su Young Park, Britta Galling, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|May 31, 2016
Antipsychotic Use Trends in Youth With Autism Spectrum Disorder and/or Intellectual Disability: A Meta-AnalysisSu Young Park, Chiara Cervesi, Britta Galling, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|June 7, 2016
Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta-analysisDavy Vancampfort, Christoph U Correll, Britta Galling, et al.
Expert Opinion on Drug Safety|March 12, 2016
Safety and tolerability of antipsychotic co-treatment in patients with schizophrenia: results from a systematic review and meta-analysis of randomized controlled trialsBritta Galling, Alexandra Roldán, Liz Rietschel, et al.
Journal of Child and Adolescent Psychopharmacology|March 16, 2016
Correlates of Subjective Caregiver Strain in Caregivers of Youth Evaluated in a Pediatric Psychiatric Emergency RoomSilvia Molteni, Maren Carbon, Johnny Lops, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|January 28, 2017
Antipsychotic augmentation vs. monotherapy in schizophrenia: systematic review, meta-analysis and meta-regression analysisBritta Galling, Alexandra Roldán, Katsuhiko Hagi, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|January 13, 2022
Early Antipsychotic Nonresponse as a Predictor of Nonresponse and Nonremission in Adolescents With Psychosis Treated With Aripiprazole or Quetiapine: Results From the TEA TrialAnne Katrine Pagsberg, Amanda Krogmann, Pia Jeppesen, et al.
JAMA Psychiatry|January 22, 2016
Type 2 Diabetes Mellitus in Youth Exposed to Antipsychotics: A Systematic Review and Meta-analysisBritta Galling, Alexandra Roldán, René E Nielsen, et al.
Schizophrenia Research|August 14, 2024
Efficacy and tolerability of antipsychotic polypharmacy for schizophrenia spectrum disorders. A systematic review and meta-analysis of individual patient dataMarc W H Lochmann van Bennekom, Joanna IntHout, Harm J Gijsman, et al.
Psychiatrische Praxis|July 3, 2015
[Early Detection and Integrated Care in Adolescents and Young Adults with Severe Psychotic Illnesses]Martin Lambert, Daniel Schöttle, Mary Sengutta, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
The Journal of Clinical Psychiatry|January 10, 2017
Extent, Time Course, and Moderators of Antipsychotic Treatment in Youth With Mood Disorders: Results of a Meta-Analysis and Meta-Regression AnalysesChiara Cervesi, Su Young Park, Britta Galling, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|May 31, 2016
Antipsychotic Use Trends in Youth With Autism Spectrum Disorder and/or Intellectual Disability: A Meta-AnalysisSu Young Park, Chiara Cervesi, Britta Galling, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|June 7, 2016
Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta-analysisDavy Vancampfort, Christoph U Correll, Britta Galling, et al.
Expert Opinion on Drug Safety|March 12, 2016
Safety and tolerability of antipsychotic co-treatment in patients with schizophrenia: results from a systematic review and meta-analysis of randomized controlled trialsBritta Galling, Alexandra Roldán, Liz Rietschel, et al.
Journal of Child and Adolescent Psychopharmacology|March 16, 2016
Correlates of Subjective Caregiver Strain in Caregivers of Youth Evaluated in a Pediatric Psychiatric Emergency RoomSilvia Molteni, Maren Carbon, Johnny Lops, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|January 28, 2017
Antipsychotic augmentation vs. monotherapy in schizophrenia: systematic review, meta-analysis and meta-regression analysisBritta Galling, Alexandra Roldán, Katsuhiko Hagi, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|January 13, 2022
Early Antipsychotic Nonresponse as a Predictor of Nonresponse and Nonremission in Adolescents With Psychosis Treated With Aripiprazole or Quetiapine: Results From the TEA TrialAnne Katrine Pagsberg, Amanda Krogmann, Pia Jeppesen, et al.
JAMA Psychiatry|January 22, 2016
Type 2 Diabetes Mellitus in Youth Exposed to Antipsychotics: A Systematic Review and Meta-analysisBritta Galling, Alexandra Roldán, René E Nielsen, et al.
Schizophrenia Research|August 14, 2024
Efficacy and tolerability of antipsychotic polypharmacy for schizophrenia spectrum disorders. A systematic review and meta-analysis of individual patient dataMarc W H Lochmann van Bennekom, Joanna IntHout, Harm J Gijsman, et al.
Psychiatrische Praxis|July 3, 2015
[Early Detection and Integrated Care in Adolescents and Young Adults with Severe Psychotic Illnesses]Martin Lambert, Daniel Schöttle, Mary Sengutta, et al.
Pageof 3